美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

66.53

-2.3800-3.45%

成交量：46.09萬

成交額：3,113.97萬

市值：46.00億

市盈率：-18.21

高：69.00

開：69.00

低：66.40

收：68.91

52周最高：94.90

52周最低：13.22

股本：6,913.92萬

流通股本：4,902.67萬

量比：0.54

換手率：0.94%

股息：- -

股息率：- -

每股收益(TTM):-3.6529

每股收益(LYR):-2.3276

淨資產收益率：-25.28%

總資產收益率：-17.53%

市淨率：5.97

市盈率(LYR):-28.58

資料載入中...

總覽公司新聞資訊公告

碩迪生物盤中異動大幅下挫5.12%報72.09美元

美國研究綜述-Cencora、Crocs、Teledyne Technologies

碩迪生物(GPCR.US)CEO憂心減肥藥仿製衝擊：即便藥物尚未上市，挑戰已在眼前

Structure Therapeutics首席執行官強調：藥品商業化戰略伙伴需與基層醫療醫生建立穩固關係

Structure 預計到 2030 年，藥片將佔據 25% 至 50% 的 GLP-1 肥胖症市場份額

未來一天的看點--1 月 14 日星期三

未來一天的看點--1 月 13 日星期二

碩迪生物盤中異動股價大漲5.13%

1億美元！碩迪生物授權羅氏GLP-1專利

医药魔方Info

BUZZ-在其他肥胖症藥物開發商業績下滑的同時，Structure Therapeutics 公司的業績翻了一番

Structure Therapeutics宣佈啓動口服小分子澱粉樣蛋白A受體激動劑Accg-2671的第一階段臨床研究以治療肥胖症

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

Structure Therapeutics宣佈成功完成747.5百萬美元的增資公開發行ADS及預付認股權證，並全面行使承銷商購買附加ADS的選項

減肥藥概念走強，GPCR升逾5%，諾和諾德升逾4%

老虎资讯综合

Structure Therapeutics宣佈增強至6.5億美元的公眾發行定價，涉及ADS和預孖展認購權證

BUZZBUZZ作響的美國股票-特斯拉、華納兄弟探索公司、Netflix

中概股逆勢上漲，碩迪生物升逾110%，比特幣突破9.1萬美元

21世纪经济报道

BUZZ--美國股票走勢-美光、NextEra Energy、Ocular Therapeutix

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

Structure 公司的實驗性藥片在研究中顯示可減輕 11% 的體重，股價上漲

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GPCR/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GPCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":66.53,"timestamp":1772053200000,"preClose":68.91,"halted":0,"volume":460892,"delay":0,"changeRate":-0.03453780293135968,"floatShares":49026700,"shares":69139200,"eps":-3.652895,"marketStatus":"盤前交易","change":-2.38,"latestTime":"02-26 05:00:05 EST","open":69,"high":69,"low":66.4,"amount":31139651.780959997,"amplitude":0.03773,"askPrice":95,"askSize":1,"bidPrice":65.51,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-3.652895,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772116200000},"marketStatusCode":1,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":66.53,"postHourTrading":{"tag":"盘后","latestPrice":66.2856,"preClose":66.53,"latestTime":"19:35 EST","volume":9856,"amount":655609.9025,"timestamp":1772066107308,"change":-0.2444,"changeRate":-0.003674,"amplitude":0.003674},"volumeRatio":0.5378505439957932,"impliedVol":0.7122,"impliedVolPercentile":0.276},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","floatShares":49026700,"roa":"-17.53%","roe":"-25.28%","lyrEps":-2.327592,"volumeRatio":0.5378505439957932,"shares":69139200,"dividePrice":0,"high":69,"amplitude":0.03773,"preClose":68.91,"low":66.4,"week52Low":13.22,"pbRate":"5.97","week52High":94.9,"institutionHeld":0,"latestPrice":66.53,"committee":0.666667,"eps":-3.652895,"divideRate":0,"volume":460892,"delay":0,"ttmEps":-3.652895,"open":69,"prevYearClose":69.55,"prevWeekClose":66.55,"prevMonthClose":88.45,"prevQuarterClose":69.55,"fiveDayClose":68.36,"twentyDayClose":89.51,"sixtyDayClose":34.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GPCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"GPCR","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-08-06","symbol":"GPCR","fiscalQuarterEnding":"2025/06","expectedEps":-0.28,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-05-08","symbol":"GPCR","fiscalQuarterEnding":"2025/03","expectedEps":-0.24,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-02-27","symbol":"GPCR","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"盤後","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2024-11-13","symbol":"GPCR","fiscalQuarterEnding":"2024/09","expectedEps":-0.19,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GPCR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GPCR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":16,"updateTime":1769230800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GPCR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GPCR","date":"2026-02-25","current":-18.212952,"percent":0.282258,"low":-50.180001,"twenty":-24.038086,"median":-18.81184,"eighty":-9.894553,"high":-5.211405,"avg":-19.04003,"sd":8.685274,"marketCap":4764381651},"quantilePoints":[{"date":"2023-02-03","current":-25.001825,"twenty":-43.272389,"median":-43.272389,"eighty":-32.310051,"marketCap":951294422},{"date":"2023-02-10","current":-22.116999,"twenty":-35.964163,"median":-23.496907,"eighty":-22.21316,"marketCap":841529681},{"date":"2023-02-17","current":-21.285207,"twenty":-24.521021,"median":-22.645883,"eighty":-21.915061,"marketCap":809880847},{"date":"2023-02-24","current":-23.36709,"twenty":-23.715192,"median":-22.645883,"eighty":-21.847749,"marketCap":889094402},{"date":"2023-03-03","current":-25.530709,"twenty":-24.422936,"median":-22.718004,"eighty":-21.972757,"marketCap":971417957},{"date":"2023-03-10","current":-22.636267,"twenty":-24.85566,"median":-22.790125,"eighty":-22.063149,"marketCap":861287334},{"date":"2023-03-17","current":-22.232392,"twenty":-24.422936,"median":-22.70358,"eighty":-22.09392,"marketCap":845920270},{"date":"2023-03-24","current":-21.876596,"twenty":-23.762311,"median":-22.568955,"eighty":-21.891982,"marketCap":832382619},{"date":"2023-03-31","current":-16.960589,"twenty":-23.565181,"median":-22.314128,"eighty":-21.634271,"marketCap":870434396},{"date":"2023-04-06","current":-17.823234,"twenty":-23.376706,"median":-22.232392,"eighty":-21.285207,"marketCap":914706175},{"date":"2023-04-14","current":-17.473898,"twenty":-23.36709,"median":-22.116999,"eighty":-18.643102,"marketCap":896777933},{"date":"2023-04-21","current":-17.210114,"twenty":-23.194,"median":-22.059302,"eighty":-17.623613,"marketCap":883240282},{"date":"2023-04-28","current":-17.815518,"twenty":-23.078607,"median":-21.876596,"eighty":-17.586227,"marketCap":914310203},{"date":"2023-05-05","current":-17.709107,"twenty":-22.982446,"median":-21.689083,"eighty":-17.623613,"marketCap":908849077},{"date":"2023-05-12","current":-17.00755,"twenty":-22.790125,"median":-21.491953,"eighty":-17.586227,"marketCap":956079400},{"date":"2023-05-19","current":-15.32957,"twenty":-22.780509,"median":-20.818827,"eighty":-17.473898,"marketCap":861751761},{"date":"2023-05-26","current":-19.808636,"twenty":-22.761276,"median":-19.808636,"eighty":-17.466769,"marketCap":1113542462},{"date":"2023-06-02","current":-21.830342,"twenty":-22.668962,"median":-20.674586,"eighty":-17.472472,"marketCap":1227192672},{"date":"2023-06-09","current":-23.110075,"twenty":-22.668962,"median":-21.38858,"eighty":-17.563702,"marketCap":1299132872},{"date":"2023-06-16","current":-21.061141,"twenty":-22.668962,"median":-21.491953,"eighty":-17.586212,"marketCap":1183952020},{"date":"2023-06-23","current":-21.782692,"twenty":-22.640113,"median":-21.568882,"eighty":-17.608538,"marketCap":1224514048},{"date":"2023-06-30","current":-27.561913,"twenty":-22.772816,"median":-21.571672,"eighty":-17.623492,"marketCap":1549392931},{"date":"2023-07-07","current":-24.451072,"twenty":-23.059375,"median":-21.612515,"eighty":-17.625039,"marketCap":1374517018},{"date":"2023-07-14","current":-21.428724,"twenty":-23.103781,"median":-21.707815,"eighty":-17.644282,"marketCap":1204615694},{"date":"2023-07-21","current":-23.069233,"twenty":-23.103781,"median":-21.780436,"eighty":-17.700571,"marketCap":1296836908},{"date":"2023-07-28","current":-23.552536,"twenty":-23.333385,"median":-21.782692,"eighty":-17.727736,"marketCap":1324005814},{"date":"2023-08-04","current":-21.592094,"twenty":-23.51737,"median":-21.782692,"eighty":-17.804907,"marketCap":1213799550},{"date":"2023-08-11","current":-19.978813,"twenty":-23.374783,"median":-21.781564,"eighty":-17.817061,"marketCap":1123108978},{"date":"2023-08-18","current":-16.072919,"twenty":-23.333385,"median":-21.735043,"eighty":-17.644282,"marketCap":1053531639},{"date":"2023-08-25","current":-16.66259,"twenty":-23.197654,"median":-21.646551,"eighty":-17.586168,"marketCap":1092182818},{"date":"2023-09-01","current":-16.458249,"twenty":-23.185384,"median":-21.592094,"eighty":-17.468195,"marketCap":1078788845},{"date":"2023-09-08","current":-16.680105,"twenty":-23.150918,"median":-21.568882,"eighty":-17.319402,"marketCap":1093330873},{"date":"2023-09-15","current":-18.326514,"twenty":-23.110075,"median":-21.460338,"eighty":-17.211393,"marketCap":1201248026},{"date":"2023-09-22","current":-19.937893,"twenty":-23.078607,"median":-21.067948,"eighty":-17.309925,"marketCap":1306869070},{"date":"2023-09-29","current":-21.876218,"twenty":-23.069233,"median":-21.012104,"eighty":-17.319402,"marketCap":1433920470},{"date":"2023-10-06","current":-37.165618,"twenty":-23.194,"median":-21.285207,"eighty":-17.395476,"marketCap":2436094784},{"date":"2023-10-13","current":-44.162453,"twenty":-23.552536,"median":-21.525005,"eighty":-17.459473,"marketCap":2894716299},{"date":"2023-10-20","current":-45.222784,"twenty":-23.852048,"median":-21.571672,"eighty":-17.466769,"marketCap":2964217822},{"date":"2023-10-27","current":-47.275909,"twenty":-23.892891,"median":-21.592094,"eighty":-17.469621,"marketCap":3098794020},{"date":"2023-11-03","current":-48.538851,"twenty":-24.328544,"median":-21.646551,"eighty":-17.490333,"marketCap":3181576088},{"date":"2023-11-10","current":-38.273225,"twenty":-24.864943,"median":-21.735043,"eighty":-17.514986,"marketCap":2508695101},{"date":"2023-11-17","current":-27.570058,"twenty":-25.04304,"median":-21.781564,"eighty":-17.543453,"marketCap":2122673903},{"date":"2023-11-24","current":-32.691508,"twenty":-27.365869,"median":-21.782692,"eighty":-17.586168,"marketCap":2516984612},{"date":"2023-12-01","current":-35.337541,"twenty":-28.3175,"median":-21.830342,"eighty":-17.593664,"marketCap":2720707940},{"date":"2023-12-08","current":-37.983573,"twenty":-33.138225,"median":-21.904522,"eighty":-17.623452,"marketCap":2924431267},{"date":"2023-12-15","current":-37.177707,"twenty":-34.105722,"median":-22.049686,"eighty":-17.625039,"marketCap":2862386033},{"date":"2023-12-22","current":-20.939825,"twenty":-34.105722,"median":-22.001606,"eighty":-17.644282,"marketCap":1612198995},{"date":"2023-12-29","current":-23.446258,"twenty":-34.065552,"median":-22.068918,"eighty":-17.684898,"marketCap":1805174329},{"date":"2024-01-05","current":-26.187472,"twenty":-34.000259,"median":-22.102574,"eighty":-17.702705,"marketCap":2016225834},{"date":"2024-01-12","current":-28.789086,"twenty":-33.67371,"median":-22.232392,"eighty":-17.746366,"marketCap":2216529345},{"date":"2024-01-19","current":-27.710368,"twenty":-33.290514,"median":-22.259189,"eighty":-17.804907,"marketCap":2133476670},{"date":"2024-01-26","current":-26.745867,"twenty":-33.138225,"median":-22.283013,"eighty":-17.817061,"marketCap":2059217807},{"date":"2024-02-02","current":-28.598724,"twenty":-32.691508,"median":-22.44298,"eighty":-17.823234,"marketCap":2201872991},{"date":"2024-02-09","current":-29.823387,"twenty":-32.667396,"median":-22.576119,"eighty":-17.835432,"marketCap":2296162205},{"date":"2024-02-16","current":-28.427399,"twenty":-32.293017,"median":-22.636267,"eighty":-17.890184,"marketCap":2188682272},{"date":"2024-02-23","current":-26.035182,"twenty":-31.181303,"median":-22.647193,"eighty":-17.91403,"marketCap":2004500750},{"date":"2024-03-01","current":-25.743294,"twenty":-31.092467,"median":-22.775115,"eighty":-17.959972,"marketCap":1982027673},{"date":"2024-03-08","current":-22.849791,"twenty":-30.933832,"median":-22.849791,"eighty":-18.031985,"marketCap":1759251085},{"date":"2024-03-15","current":-18.291889,"twenty":-29.823387,"median":-22.775115,"eighty":-18.031985,"marketCap":1639319082},{"date":"2024-03-22","current":-22.815466,"twenty":-29.601298,"median":-22.761276,"eighty":-18.070517,"marketCap":2044722039},{"date":"2024-03-28","current":-22.311113,"twenty":-29.398245,"median":-22.645883,"eighty":-18.070517,"marketCap":1999521939},{"date":"2024-04-05","current":-20.434088,"twenty":-29.301795,"median":-22.601624,"eighty":-18.089549,"marketCap":1831303011},{"date":"2024-04-12","current":-20.928042,"twenty":-29.107626,"median":-22.568955,"eighty":-18.098906,"marketCap":1875571150},{"date":"2024-04-19","current":-18.81184,"twenty":-29.061939,"median":-22.455039,"eighty":-18.224405,"marketCap":1685917123},{"date":"2024-04-26","current":-20.267704,"twenty":-28.863962,"median":-22.311113,"eighty":-18.256547,"marketCap":1816391638},{"date":"2024-05-03","current":-20.281918,"twenty":-28.794162,"median":-22.289169,"eighty":-18.270537,"marketCap":1817665530},{"date":"2024-05-10","current":-20.105056,"twenty":-28.789086,"median":-22.270856,"eighty":-18.288305,"marketCap":1801815151},{"date":"2024-05-17","current":-17.123915,"twenty":-28.636796,"median":-22.232392,"eighty":-18.098906,"marketCap":1672681180},{"date":"2024-05-24","current":-18.288418,"twenty":-28.476893,"median":-22.116999,"eighty":-18.062811,"marketCap":1786430959},{"date":"2024-05-31","current":-16.11295,"twenty":-28.435013,"median":-22.068918,"eighty":-17.902107,"marketCap":1573929112},{"date":"2024-06-07","current":-26.55105,"twenty":-28.381712,"median":-22.102574,"eighty":-17.902107,"marketCap":2593533072},{"date":"2024-06-14","current":-24.646705,"twenty":-28.337752,"median":-22.198735,"eighty":-17.932407,"marketCap":2407514791},{"date":"2024-06-21","current":-22.312809,"twenty":-28.3175,"median":-22.24579,"eighty":-17.974375,"marketCap":2179537500},{"date":"2024-06-28","current":-18.680713,"twenty":-28.3175,"median":-22.24579,"eighty":-18.00318,"marketCap":1824750754},{"date":"2024-07-05","current":-17.874111,"twenty":-28.267548,"median":-22.198735,"eighty":-17.932407,"marketCap":1745961056},{"date":"2024-07-12","current":-20.408464,"twenty":-28.068249,"median":-22.08815,"eighty":-17.932407,"marketCap":1993519219},{"date":"2024-07-15","current":-20.943017,"twenty":-28.006064,"median":-22.078534,"eighty":-17.941595,"marketCap":2045734877},{"date":"2024-08-02","current":-17.387286,"twenty":-27.943879,"median":-22.068918,"eighty":-17.908069,"marketCap":1698407510},{"date":"2024-08-09","current":-16.461364,"twenty":-27.802578,"median":-21.942986,"eighty":-17.823234,"marketCap":1607962532},{"date":"2024-08-16","current":-20.792004,"twenty":-27.780694,"median":-21.876596,"eighty":-17.821691,"marketCap":2088244945},{"date":"2024-08-23","current":-22.295452,"twenty":-27.74971,"median":-21.929398,"eighty":-17.823234,"marketCap":2239243758},{"date":"2024-08-30","current":-21.822777,"twenty":-27.716713,"median":-21.953525,"eighty":-17.863936,"marketCap":2191770646},{"date":"2024-09-06","current":-21.851252,"twenty":-27.691332,"median":-21.926349,"eighty":-17.874111,"marketCap":2194630472},{"date":"2024-09-13","current":-22.944669,"twenty":-27.671026,"median":-21.901472,"eighty":-17.880178,"marketCap":2304447790},{"date":"2024-09-20","current":-22.067657,"twenty":-27.608415,"median":-21.926349,"eighty":-17.902107,"marketCap":2216365150},{"date":"2024-09-27","current":-23.650834,"twenty":-27.565171,"median":-22.001606,"eighty":-17.941595,"marketCap":2375371475},{"date":"2024-10-04","current":-24.083644,"twenty":-27.536769,"median":-22.068918,"eighty":-18.000093,"marketCap":2418840830},{"date":"2024-10-11","current":-22.130301,"twenty":-27.481934,"median":-22.12365,"eighty":-18.029927,"marketCap":2222656767},{"date":"2024-10-18","current":-22.563112,"twenty":-27.163394,"median":-22.116999,"eighty":-18.055104,"marketCap":2266126122},{"date":"2024-10-25","current":-21.333018,"twenty":-26.967956,"median":-22.11226,"eighty":-18.070517,"marketCap":2142581639},{"date":"2024-10-31","current":-21.560813,"twenty":-26.932422,"median":-22.097835,"eighty":-18.080033,"marketCap":2165460247},{"date":"2024-11-08","current":-21.839862,"twenty":-26.875803,"median":-22.107521,"eighty":-18.096607,"marketCap":2193486542},{"date":"2024-11-15","current":-19.500107,"twenty":-26.820843,"median":-22.068288,"eighty":-18.16223,"marketCap":2155736838},{"date":"2024-11-22","current":-15.573182,"twenty":-26.740791,"median":-22.039183,"eighty":-18.047398,"marketCap":1721615252},{"date":"2024-11-29","current":-17.170432,"twenty":-26.702879,"median":-21.932448,"eighty":-17.923218,"marketCap":1898191276},{"date":"2024-12-06","current":-16.181125,"twenty":-26.575564,"median":-21.883856,"eighty":-17.833409,"marketCap":1788823393},{"date":"2024-12-13","current":-16.424567,"twenty":-26.524021,"median":-21.851252,"eighty":-17.817061,"marketCap":1815735909},{"date":"2024-12-20","current":-15.523314,"twenty":-26.386717,"median":-21.835102,"eighty":-17.715324,"marketCap":1716102339},{"date":"2024-12-27","current":-15.30059,"twenty":-26.269962,"median":-21.822777,"eighty":-17.687076,"marketCap":1691480250},{"date":"2025-01-03","current":-14.601342,"twenty":-26.20397,"median":-21.78933,"eighty":-17.625803,"marketCap":1614178343},{"date":"2025-01-10","current":-14.005686,"twenty":-26.17605,"median":-21.782692,"eighty":-17.604018,"marketCap":1548328570},{"date":"2025-01-17","current":-13.974608,"twenty":-26.160821,"median":-21.780436,"eighty":-17.514986,"marketCap":1544892930},{"date":"2025-01-24","current":-14.482211,"twenty":-26.10752,"median":-21.737354,"eighty":-17.469621,"marketCap":1601008389},{"date":"2025-01-31","current":-15.7046,"twenty":-26.035182,"median":-21.700984,"eighty":-17.381485,"marketCap":1736143575},{"date":"2025-02-07","current":-15.549212,"twenty":-26.032644,"median":-21.680405,"eighty":-17.295679,"marketCap":1718965373},{"date":"2025-02-14","current":-12.622728,"twenty":-25.9819,"median":-21.605123,"eighty":-17.234446,"marketCap":1395442576},{"date":"2025-02-21","current":-12.115125,"twenty":-25.903236,"median":-21.581883,"eighty":-17.21037,"marketCap":1339327118},{"date":"2025-02-28","current":-11.819887,"twenty":-25.84482,"median":-21.567582,"eighty":-17.171628,"marketCap":1306688535},{"date":"2025-03-07","current":-11.01217,"twenty":-25.735679,"median":-21.559435,"eighty":-17.124089,"marketCap":1349277189},{"date":"2025-03-14","current":-9.547313,"twenty":-25.689992,"median":-21.491953,"eighty":-17.045645,"marketCap":1169794078},{"date":"2025-03-21","current":-10.235281,"twenty":-25.609403,"median":-21.417887,"eighty":-16.960589,"marketCap":1254088063},{"date":"2025-03-28","current":-9.33203,"twenty":-25.527539,"median":-21.321628,"eighty":-16.93886,"marketCap":1143416369},{"date":"2025-04-04","current":-7.64253,"twenty":-25.480594,"median":-21.202701,"eighty":-16.831205,"marketCap":936408691},{"date":"2025-04-11","current":-7.043483,"twenty":-25.340669,"median":-21.061141,"eighty":-16.666093,"marketCap":863009847},{"date":"2025-04-17","current":-8.672143,"twenty":-25.329214,"median":-21.042579,"eighty":-16.563339,"marketCap":1062562954},{"date":"2025-04-25","current":-11.068331,"twenty":-25.25285,"median":-20.951128,"eighty":-16.426861,"marketCap":1356158331},{"date":"2025-05-02","current":-12.790591,"twenty":-25.171712,"median":-20.933479,"eighty":-16.305436,"marketCap":1567180008},{"date":"2025-05-09","current":-12.551909,"twenty":-25.070517,"median":-20.891345,"eighty":-16.181125,"marketCap":1537935156},{"date":"2025-05-16","current":-9.774326,"twenty":-25.068859,"median":-20.829252,"eighty":-16.056814,"marketCap":1400885752},{"date":"2025-05-23","current":-9.895696,"twenty":-25.0453,"median":-20.693431,"eighty":-15.839386,"marketCap":1418280862},{"date":"2025-05-30","current":-9.000467,"twenty":-25.01052,"median":-20.672234,"eighty":-15.745511,"marketCap":1289973912},{"date":"2025-06-06","current":-8.619091,"twenty":-25.001825,"median":-20.550917,"eighty":-15.544032,"marketCap":1235314001},{"date":"2025-06-13","current":-8.920177,"twenty":-24.996225,"median":-20.487391,"eighty":-15.387426,"marketCap":1278466562},{"date":"2025-06-20","current":-8.679308,"twenty":-24.952868,"median":-20.449033,"eighty":-14.973238,"marketCap":1243944513},{"date":"2025-06-27","current":-8.462526,"twenty":-24.918331,"median":-20.434088,"eighty":-14.66039,"marketCap":1212874668},{"date":"2025-07-03","current":-8.175491,"twenty":-24.875783,"median":-20.408464,"eighty":-14.607558,"marketCap":1171735893},{"date":"2025-07-11","current":-7.587369,"twenty":-24.818526,"median":-20.385744,"eighty":-14.451133,"marketCap":1087444556},{"date":"2025-07-18","current":-7.840282,"twenty":-24.807686,"median":-20.281918,"eighty":-14.123781,"marketCap":1123692707},{"date":"2025-07-25","current":-7.334457,"twenty":-24.781668,"median":-20.180483,"eighty":-13.987039,"marketCap":1051196404},{"date":"2025-08-01","current":-7.145777,"twenty":-24.722332,"median":-20.085721,"eighty":-13.108576,"marketCap":1024154132},{"date":"2025-08-08","current":-5.211405,"twenty":-24.651853,"median":-19.971704,"eighty":-12.812535,"marketCap":932580977},{"date":"2025-08-15","current":-5.964179,"twenty":-24.61951,"median":-19.937893,"eighty":-12.626872,"marketCap":1067289809},{"date":"2025-08-22","current":-6.234546,"twenty":-24.540145,"median":-19.829477,"eighty":-12.490132,"marketCap":1115672078},{"date":"2025-08-29","current":-6.160517,"twenty":-24.4698,"median":-19.66456,"eighty":-12.119485,"marketCap":1102424552},{"date":"2025-09-05","current":-6.360074,"twenty":-24.389808,"median":-19.576169,"eighty":-11.77845,"marketCap":1138135274},{"date":"2025-09-12","current":-6.720564,"twenty":-24.139365,"median":-19.456275,"eighty":-11.057099,"marketCap":1202644966},{"date":"2025-09-19","current":-7.47695,"twenty":-24.11098,"median":-19.134734,"eighty":-10.896967,"marketCap":1338000122},{"date":"2025-09-26","current":-8.043434,"twenty":-24.072254,"median":-19.014985,"eighty":-10.567565,"marketCap":1439372495},{"date":"2025-10-03","current":-8.568076,"twenty":-24.020356,"median":-18.941828,"eighty":-10.325716,"marketCap":1533257136},{"date":"2025-10-10","current":-9.833009,"twenty":-23.986828,"median":-18.81071,"eighty":-10.186609,"marketCap":1759617036},{"date":"2025-10-17","current":-8.87063,"twenty":-23.947347,"median":-18.74276,"eighty":-9.917033,"marketCap":1587399198},{"date":"2025-10-24","current":-8.548764,"twenty":-23.914099,"median":-18.661907,"eighty":-9.852324,"marketCap":1529801259},{"date":"2025-10-31","current":-10.370526,"twenty":-23.886602,"median":-18.351918,"eighty":-9.836476,"marketCap":1855805594},{"date":"2025-11-07","current":-10.772858,"twenty":-23.868757,"median":-18.327399,"eighty":-9.850579,"marketCap":1927803018},{"date":"2025-11-14","current":-10.08006,"twenty":-23.852048,"median":-18.288418,"eighty":-9.817863,"marketCap":2123717400},{"date":"2025-11-21","current":-9.889979,"twenty":-23.841601,"median":-18.256152,"eighty":-9.836476,"marketCap":2083670157},{"date":"2025-11-28","current":-10.313341,"twenty":-23.799814,"median":-18.097181,"eighty":-9.841018,"marketCap":2172866288},{"date":"2025-12-05","current":-9.460856,"twenty":-23.776121,"median":-18.070517,"eighty":-9.814076,"marketCap":1993260474},{"date":"2025-12-12","current":-19.422835,"twenty":-23.650834,"median":-18.082412,"eighty":-9.833009,"marketCap":4092100041},{"date":"2025-12-19","current":-17.985707,"twenty":-23.62393,"median":-18.070517,"eighty":-9.841018,"marketCap":3789318618},{"date":"2025-12-26","current":-22.869735,"twenty":-23.621272,"median":-18.100056,"eighty":-9.848479,"marketCap":4818310220},{"date":"2026-01-02","current":-22.823793,"twenty":-23.615623,"median":-18.255492,"eighty":-9.851048,"marketCap":4808630734},{"date":"2026-01-09","current":-21.980412,"twenty":-23.576442,"median":-18.281194,"eighty":-9.851517,"marketCap":4630943013},{"date":"2026-01-16","current":-27.900487,"twenty":-23.621936,"median":-18.326514,"eighty":-9.853937,"marketCap":5878214018},{"date":"2026-01-23","current":-30.148409,"twenty":-23.790337,"median":-18.349084,"eighty":-9.86147,"marketCap":6351817477},{"date":"2026-01-30","current":-28.599475,"twenty":-23.883185,"median":-18.63625,"eighty":-9.874048,"marketCap":6025480495},{"date":"2026-02-06","current":-24.024872,"twenty":-24.012922,"median":-18.680713,"eighty":-9.881446,"marketCap":5061680173},{"date":"2026-02-13","current":-23.64092,"twenty":-24.104146,"median":-18.735704,"eighty":-9.886523,"marketCap":4980787319},{"date":"2026-02-20","current":-22.141212,"twenty":-24.072254,"median":-18.787312,"eighty":-9.891122,"marketCap":4664821216},{"date":"2026-02-25","current":-22.613768,"twenty":-24.038086,"median":-18.81184,"eighty":-9.894553,"marketCap":4764381651}],"updateTime":1772100005746},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GPCR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611698391","title":"碩迪生物盤中異動 大幅下挫5.12%報72.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611698391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611698391?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 04:59","pubTimestamp":1770929957,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日04时59分，硕迪生物股票出现异动，股价急速跳水5.12%。截至发稿，该股报72.09美元/股，成交量42.8565万股，换手率0.61%，振幅6.59%。机构评级方面，在所有16家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213045917a6f4a6c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213045917a6f4a6c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2605450753","title":"美國研究綜述-Cencora、Crocs、Teledyne Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605450753","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605450753?lang=zh_tw&edition=fundamental","pubTime":"2026-01-22 15:18","pubTimestamp":1769066301,"startTime":"0","endTime":"0","summary":"美国研究综述-Cencora、Crocs、Teledyne Technologies路透1月22日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Cencora、Crocs 和 Teledyne Technologies。* HCA Healthcare Inc HCA.N：杰富瑞将目标价从525美元上调至535美元* Teledyne Technologies Inc TDY.N：Needham将目标价从615美元上调至700美元以下是路透周四报道的美国公司研究报告摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL4S3YN0FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH","UAL","CNC","WY","GLDD","MCB","MKSI","HAL","KTOS","CHE","CTSH","REAL","BKU","BXP","MRK","COR","KRMN","GOLF","ACHC","WTFC","LU2413666004.HKD","DCOM","OPCH","KMI","CFG","ORN","TDY","EOLS","GDRX","CROX","LEGN","CVLT","NIC","IE00B19Z4B17.USD","GPCR","OZK","BTSG","HCA","MOH","SSNC","EGBN","SCHW","LU1066053197.SGD","FOLD","LU0345770993.USD","LU1032955483.USD","JNJ","RAPT"],"gpt_icon":1},{"id":"2603679993","title":"碩迪生物(GPCR.US)CEO憂心減肥藥仿製衝擊：即便藥物尚未上市，挑戰已在眼前","url":"https://stock-news.laohu8.com/highlight/detail?id=2603679993","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603679993?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 14:51","pubTimestamp":1768459909,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，硕迪生物首席执行官Raymond Stevens周三在旧金山举行的摩根大通医疗保健大会上接受采访时表示，硕迪生物的实验性减肥药尚未获得批准，但已开始担心其试验性减肥药的仿制版本大量涌入市场。在礼来和诺和诺德推出减肥针剂后的几年里，由于供应短缺，患者转而使用仿制或配制的减肥药。9月份，该机构在一份声明中表示，为了阻止进口可能存在危险的活性成分仿制品，它将公布一份符合该机构标准的海外供应商名单。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"1159085975","title":"Structure Therapeutics首席執行官強調：藥品商業化戰略伙伴需與基層醫療醫生建立穩固關係","url":"https://stock-news.laohu8.com/highlight/detail?id=1159085975","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159085975?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 04:05","pubTimestamp":1768421109,"startTime":"0","endTime":"0","summary":"Structure Therapeutics公司首席执行官近日指出，其药物商业化进程中的战略合作伙伴必须具备与初级保健医生群体的深厚联系。这一表态凸显了在医药产品推广阶段，直接触及一线处方决策者的关键性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2603764194","title":"Structure 預計到 2030 年，藥片將佔據 25% 至 50% 的 GLP-1 肥胖症市場份額","url":"https://stock-news.laohu8.com/highlight/detail?id=2603764194","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603764194?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 03:58","pubTimestamp":1768420720,"startTime":"0","endTime":"0","summary":"Structure 预计到 2030 年，药片将占据 25% 至 50% 的 GLP-1 肥胖症市场份额路透1月14日 - Structure Therapeutics GPCR.O公司周三表示，预计到2030年，口服减肥药将占据GLP-1市场25%至50%的份额。公司首席执行官称，这一乐观估计部分是受患者和医生对口服药物的积压需求所推动。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nL4T3YF1TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2603378936","title":"未來一天的看點--1 月 14 日星期三","url":"https://stock-news.laohu8.com/highlight/detail?id=2603378936","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603378936?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 03:33","pubTimestamp":1768332791,"startTime":"0","endTime":"0","summary":"未来一天的看点--1 月 14 日星期三The Day Ahead 是一份电子邮件和 PDF 格式的出版物，内容包括当天的主要新闻和事件、分析和其他专题。从全年来看，生产者价格指数可能上涨 2.7%，与此前涨幅相近。除食品和能源外，11 月份PPI环比增长 0.2%，同比增长 2.7%。另外，美国商务部人口普查局将公布 11 月份零售销售报告，预计将增长 0.4%，10 月份为持平。全美房地产经纪人协会预计 12 月份成屋销售量为 421 万套，高于 11 月份的 413 万套。美联储将在当日安排一系列发言人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4T3YE1WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU0820561818.USD","LU2361045086.USD","LU1670628061.USD","LU1585245621.USD","LU1989771016.USD","LU2237443622.USD","IE00BN8TJ469.HKD","LU2237443978.SGD","LU1880398554.USD","LU1670710588.SGD","IE00B1XK9C88.USD","LU1244550494.USD","IE00BFXG1179.USD","BK4532","LU2381873111.SGD","LU0314106906.USD","LU1323610961.USD","LU2264538146.SGD","LU0251132253.USD","LU0496365809.HKD","LU1571399168.USD","LU0868494617.USD","LU2023250330.USD","BAC","LU1974910355.USD","LU1116320737.USD","LU0128525689.USD","LU1496350502.SGD","LU2125154778.USD","LU2357305700.SGD","LU1162221912.USD","GPCR","BK4007","LU0225771236.USD","LU0265550946.USD","LU1032466523.USD","LU1267930490.SGD","LU2237443549.SGD","LU2265009873.SGD","IE00B19Z3581.USD","LU2213496289.HKD","LU0098860793.USD","LU0251131958.USD","LU0310800965.SGD","LU0323591593.USD","LU1244550577.SGD","IE00BSNM7G36.USD","LU0211327993.USD","BMY"],"gpt_icon":0},{"id":"2603523923","title":"未來一天的看點--1 月 13 日星期二","url":"https://stock-news.laohu8.com/highlight/detail?id=2603523923","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603523923?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 03:31","pubTimestamp":1768246263,"startTime":"0","endTime":"0","summary":"未来一天的看点--1 月 13 日星期二The Day Ahead 是一份电子邮件和 PDF 格式的出版物，内容包括当天的主要新闻和事件、分析和其他专题。此外，人口普查局的 10 月份新屋销售报告预计将显示总销售量为 72 万套，而 9 月份为 80 万套。另外，阿根廷 12 月份消费者价格指数将公布，预计将上涨 2.5%，与 11 月份的涨幅相同。按年率计算，CPI 可能会增长 31%，比 11 月份的 31.4% 略有放缓。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nL4T3YD1OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1145028129.USD","BK4500","LU0238689110.USD","BK4566","LU0211331839.USD","LU0820562030.AUD","LU0868494708.USD","IE00B1XK9C88.USD","LU0345769128.USD","LU0689472784.USD","LU1551013342.USD","LU0203347892.USD","IE00BYXW3230.USD","LU0310799852.SGD","LU0256863811.USD","IE00BJLML261.HKD","BK4516","IE00BJTD4V19.USD","LU0215105999.USD","LU0052756011.USD","LU0496365809.HKD","IE00B775SV38.USD","LU0128525689.USD","LU0942090050.USD","LU1244550494.USD","LU1917777945.USD","LU2237443978.SGD","BK4008","LU1894683264.USD","LU0976567544.SGD","LU1162221912.USD","LU2237443382.USD","LU1894683348.USD","LU2357305700.SGD","LU2462157665.USD","LU0211326755.USD","LU2237443622.USD","LU2552382215.SGD","LU2552382132.HKD","LU0048584097.USD","GPCR","BK4007","LU1244550577.SGD","DAL","LU1720051108.HKD","LU2552382058.USD","BK4504","LU0820561909.HKD","LU2237443549.SGD","IE0034235295.USD"],"gpt_icon":0},{"id":"2601812270","title":"碩迪生物盤中異動 股價大漲5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601812270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601812270?lang=zh_tw&edition=fundamental","pubTime":"2026-01-06 22:47","pubTimestamp":1767710851,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日22时47分，硕迪生物股票出现波动，股价大幅拉升5.13%。截至发稿，该股报65.99美元/股，成交量7.9455万股，换手率0.11%，振幅4.25%。机构评级方面，在所有14家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010622473297a12131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010622473297a12131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2601127868","title":"1億美元！碩迪生物授權羅氏GLP-1專利","url":"https://stock-news.laohu8.com/highlight/detail?id=2601127868","media":"医药魔方Info","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601127868?lang=zh_tw&edition=fundamental","pubTime":"2026-01-06 15:41","pubTimestamp":1767685313,"startTime":"0","endTime":"0","summary":"2025年12月30日，Structure Therapeutics通过其子公司Gasherbrum Bio与罗氏和基因泰克达成了一项非独家专利许可协议，并获得了1亿美元的预付款。若一方出现重大违约且未能纠正，或基因泰克对授权专利的有效性提出质疑，硕迪生物均有权终止本协议。这笔1亿美元的现金注入，为硕迪生物带来了非稀释性资金，可助力其在竞争激烈的GLP-1赛道推进临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106155205a4a258bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106155205a4a258bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4144","GLP","GPCR","BK4590","BK4007","BK4599"],"gpt_icon":0},{"id":"2595777671","title":"BUZZ-在其他肥胖症藥物開發商業績下滑的同時，Structure Therapeutics 公司的業績翻了一番","url":"https://stock-news.laohu8.com/highlight/detail?id=2595777671","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595777671?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 22:29","pubTimestamp":1767191377,"startTime":"0","endTime":"0","summary":"BUZZ-在其他肥胖症药物开发商业绩下滑的同时，Structure Therapeutics 公司的业绩翻了一番12月31日 - ** Structure Therapeutics GPCR.O的股价在2024年下跌33%之后，今年已经翻了一番多。** Altimmune 的股价今年已下跌 49.9%，将连续第三年下跌。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nL4T3Y10LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013425.SGD","GB00BDT5M118.USD","LU1720051108.HKD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU2491050154.USD","LU0316494557.USD","LU0238689110.USD","LU1623119135.USD","SG9999014906.USD","LU0823434583.USD","LU2552382132.HKD","LU1868836757.USD","LU0820561909.HKD","LU2236285917.USD","LU0122379950.USD","LU1093756168.USD","LU2491049909.HKD","IE00BFTCPJ56.SGD","LU0471298777.SGD","LU0689472784.USD","LU2602419157.SGD","SG9999014914.USD","LU2360106947.USD","IE00B7KXQ091.USD","SGXZ31699556.SGD","LU0114720955.EUR","LU0198837287.USD","SG9999017495.SGD","LU1061106388.HKD","IE00B2B36J28.USD","LU0096364046.USD","LU2456880835.USD","SGXZ51526630.SGD","SG9999015952.SGD","LU2417539215.USD","SGXZ57979304.SGD","BK4516","LU0353189680.USD","LU0432979614.USD","LU1035775433.USD","IE00BWXC8680.SGD","SG9999013999.USD","LU0106261372.USD","LU0787776722.HKD","BK4139","LU2168564149.EUR","LU2168564222.USD","LU2468319806.SGD","GPCR","LU2237438978.USD","IE00B4JS1V06.HKD","LU2237443895.HKD","LU2023250504.SGD","LU2361044949.HKD","LU1868837136.USD","LU2750360641.GBP","LU0672654240.SGD","LU2089984988.USD","LU1280957306.USD","LU0456855351.SGD","LU2237443465.HKD","LU2491050071.SGD","SG9999015978.USD","LU0466842654.USD","LU2361044865.SGD","LU2237443978.SGD","LU0289739699.SGD","IE00BKPKM429.USD","LU0354030511.USD","IE00BN29S564.USD","LU0385154629.USD","LU1323610961.USD","LU2462157665.USD","BK4581","IE00B1XK9C88.USD","LU1804176565.USD","BK4533","LU0683600562.USD","IE00BFSS7M15.SGD","LU1064131342.USD","LU1868837300.USD","LU2361045086.USD","LU1868836591.USD","SG9999014898.SGD","LU0079474960.USD","LU2168564495.EUR","SG9999014880.SGD","IE00BJJMRY28.SGD","LU1366192091.USD","LU2461242641.AUD","SG9999001176.SGD","LU2237443622.USD","SG9999018865.SGD","IE0005OL40V9.USD","LU0256863902.USD","LU0823416689.USD","LU2106854487.HKD","LU2264538146.SGD","LU0234572021.USD","LU0354030438.USD","LU0256863811.USD","IE0002141913.USD","LU1093756325.SGD","IE00BJLML261.HKD","LU0094547139.USD","LU0353189763.USD","LU0471298694.HKD","LU1974910355.USD","LU0097036916.USD","LU1127390331.HKD","LU1551013342.USD","LU2087625088.SGD","LU0266013472.USD","LU0943347566.SGD","LU2108987350.USD","LU0786609619.USD","LU2211815571.USD","LU0708995401.HKD","LU0823434740.USD","BK4585","BK4599","LU0882574055.USD","LU2168564065.EUR","IE00BK4W5M84.HKD","LU1291159041.SGD","LU1548497426.USD","LU0061475181.USD","LU0417517546.SGD","LU2112291526.USD","LU1069344957.HKD","LU0006306889.USD","SGXZ99366536.SGD","LU2552382058.USD","BK4007","LU1720051017.SGD","SG9999015945.SGD","LU0820561818.USD","LU1989771016.USD","LU2471134796.USD","LU2324357040.USD","BK4588","LU2552382215.SGD","LU2265009873.SGD","IE0004445015.USD","LU0320765992.SGD","LU0882574139.USD","LU0058720904.USD","SG9999018857.SGD","LU0320765059.SGD","LU2237443549.SGD","LU2471134523.USD","LU0109391861.USD","LU1267930730.SGD","LU1814569148.SGD","LU2168563687.JPY","LU2750360997.AUD","LU2237443382.USD","LU1232071149.USD","IE00B775H168.HKD","LU1712237335.SGD","LU1868836914.USD","LU0203201768.USD","LU0640476718.USD","LU1023059063.AUD","LU2357305700.SGD","LU0203202063.USD","LU1917777945.USD","LU1983299246.USD","LU0323591593.USD","LU2746668461.USD","BK4534","IE0009355771.USD","IE00BJJMRX11.SGD","SGXZ81514606.USD","IE0004445239.USD","IE00BJJMRZ35.SGD","IE00BFSS8Q28.SGD","SG9999001176.USD","LU2471134879.HKD","IE00BKDWB100.SGD","LU0109394709.USD","LU1878469433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU2746668974.SGD","SG9999015986.USD","IE00B1BXHZ80.USD","LU2471134952.CNY","IE00BK4W5L77.USD","LU1988902786.USD"],"gpt_icon":0},{"id":"1194056049","title":"Structure Therapeutics宣佈啓動口服小分子澱粉樣蛋白A受體激動劑Accg-2671的第一階段臨床研究以治療肥胖症","url":"https://stock-news.laohu8.com/highlight/detail?id=1194056049","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194056049?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 21:32","pubTimestamp":1765978346,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布启动口服小分子淀粉样蛋白A受体激动剂Accg-2671的第一阶段临床研究以治疗肥胖症","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2590505938","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505938","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505938?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 20:04","pubTimestamp":1765541053,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场修改日期线，在第 19、20、27、36 和 54 段增加新的细节。今年8月，该制药公司称其试验性减肥药orforglipron ，在一项晚期试验中，以36毫克的最高剂量服用72周，可帮助患有2型糖尿病的超重成年人减轻10.5%的体重。服用最高剂量Ozempic的糖尿病患者体重大约减轻了6%。礼来公司希望在今年年底前获得监管部门对orfglipron的批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4S3XI0UM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044865.SGD","LU2491050154.USD","02105","OPK","ALT","LU1989772923.USD","VKTX","LU2114397693.USD","MTSR","BK4588","LU1066051811.HKD","LU0208291251.USD","LU1551013425.SGD","LU0786609619.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU1084165304.USD","600196","LU0345777659.USD","LU0310800379.SGD","LU1116320901.HKD","SRRK","LU0203345920.USD","LU1037948897.HKD","LU1917777945.USD","LU2237443622.USD","LU0058720904.USD","BK0183","MRK","LU0784383803.USD","AZN.UK","03692","LU0969580561.USD","LU1894683348.USD","LU2023250504.SGD","SG9999014914.USD","LU0689472784.USD","LU1003076772.USD","PFE","03933","LLY","00656","GPCR","LU1929549753.HKD","LU1057294990.SGD","03165","LU0949170772.SGD","IE0002141913.USD","AMGN","LU0575583348.USD"],"gpt_icon":1},{"id":"1151839452","title":"Structure Therapeutics宣佈成功完成747.5百萬美元的增資公開發行ADS及預付認股權證，並全面行使承銷商購買附加ADS的選項","url":"https://stock-news.laohu8.com/highlight/detail?id=1151839452","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151839452?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 05:02","pubTimestamp":1765486953,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布成功完成747.5百万美元的增资公开发行ADS及预付认股权证，并全面行使承销商购买附加ADS的选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"1169452002","title":"減肥藥概念走強，GPCR升逾5%，諾和諾德升逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169452002","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169452002?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 23:26","pubTimestamp":1765380382,"startTime":"0","endTime":"0","summary":"罗氏控股涨超3%，礼来跟涨。","market":"us","thumbnail":"https://static.tigerbbs.com/5680d8f4d3b53955520e696fc46611e4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5680d8f4d3b53955520e696fc46611e4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8c3694a08f44a67f8ee972cef2b11b95","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","NVO","GPCR","RHHBY"],"gpt_icon":0},{"id":"1183719988","title":"Structure Therapeutics宣佈增強至6.5億美元的公眾發行定價，涉及ADS和預孖展認購權證","url":"https://stock-news.laohu8.com/highlight/detail?id=1183719988","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183719988?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 12:16","pubTimestamp":1765340172,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布增强至6.5亿美元的公众发行定价，涉及ADS和预融资认购权证","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"2590352974","title":"BUZZBUZZ作響的美國股票-特斯拉、華納兄弟探索公司、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2590352974","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590352974?lang=zh_tw&edition=fundamental","pubTime":"2025-12-09 00:22","pubTimestamp":1765210942,"startTime":"0","endTime":"0","summary":"nL6N3XE0OV ** NextEra Energy Inc NEE.N:BUZZ - 因谷歌扩大合作关系和 Meta 清洁能源交易而上涨  nL4N3XE0XS ** Ocular Therapeutix Inc OCUL.O:BUZZ - 因计划快速向 FDA 申请眼疾药物而上涨 nL4N3XE1AA ** Kymera Therapeutics Inc KYMR.O:BUZZ - 因湿疹药物数据良好而上涨  nL6N3XE0P9 ** Compass Inc COMP.N:BUZZ - 巴克莱将 Compass 评为 \"增持\"；股价上涨 nL4N3XE0UU ** CoreWeave Inc CRWV.O:BUZZ - 宣布发行 20 亿美元可转换债券；股价下跌 nL6N3XE0PV ** Recursion Pharmaceuticals Inc RXRX.O:BUZZ - 在罕见病试验中，实验性药物减少了息肉的生长，股价上涨   nL4N3XE0VV ** Fulcrum Therapeutics Inc FULC.O:BUZZ - 血液疾病药物试验数据公布后股价跳涨   nL4N3XE19X ** 永利度假村WYNN.O:BUZZ -","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4S3XE1FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHUA","FIVE","ARE","APD","RIOT","EOG","BHP.AU","CFLT","COMP","OCUL","APA","RIVN","GM","USCB","RIO.UK","MHUAF","NRIX","ALB","AGIO","WYNN","ACLX","SCCO","LEN","JBL","AR","INCY","LITB","MMM","IBM","CETX","FCX","JEF","WVE","KYMR","NFLX","GPCR","TSLA","DYN","CVNA","FANG","WRBY"],"gpt_icon":1},{"id":"2590352124","title":"中概股逆勢上漲，碩迪生物升逾110%，比特幣突破9.1萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590352124","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590352124?lang=zh_tw&edition=fundamental","pubTime":"2025-12-09 00:13","pubTimestamp":1765210437,"startTime":"0","endTime":"0","summary":"北京时间12月8日晚，美股三大指数高开后翻绿，中概股逆势上涨，黄金白银全线飘绿，比特币短线走高升破91000美元。中概股逆势上涨，中国金龙指数涨约0.3%，虎牙涨近8%，大全新能源涨6.4%，百度集团涨超3%。下跌方面，泡泡玛特美股跌约8%。硕迪生物盘前大涨30%，开盘后一路走高，截至发稿涨幅已高达117%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512093585643984.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512093585643984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4594","GPCR","83042","BK1611","BTC","BK4585","BK4588","BK4601"],"gpt_icon":0},{"id":"2589597873","title":"BUZZ--美國股票走勢-美光、NextEra Energy、Ocular Therapeutix","url":"https://stock-news.laohu8.com/highlight/detail?id=2589597873","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589597873?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 22:34","pubTimestamp":1765204460,"startTime":"0","endTime":"0","summary":"12月8日 - 美国股指期货周一小幅走高，原因是投资者认为美联储将在本周晚些时候举行期待已久的降息会议，而这次会议将是多年来分歧最大的会议之一。** Incyte Corp INCY.O:BUZZ - 抗体疗法在罕见血癌中显示出潜力后上涨 [完整报道 ]** Structure Therapeutics Inc GPCR.O:BUZZ - 减肥药物中期试验成功后上涨 [完整报道 ]。** Ocular Therapeutix Inc OCUL.O:BUZZ - 因计划快速向 FDA 申请眼疾药物而上涨 [完整报道 ]。** Kymera Therapeutics Inc KYMR.O:BUZZ - 因湿疹药物数据良好而上涨 [全文 ]。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4S3XE16L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEN","RIO.UK","AGIO","SCCO","CVNA","FANG","ALB","IBM","MMM","TSYW.SI","KYMR","COMP","CRH","RIO.AU","RIOT","WVE","BHP.AU","BK4511","HUT","GPCR","GM","INCY","NEE","COP","OCUL","MU","EOG","JEF","APA","ACLX","CFLT","FULC","FCX","WYNN","USCB","DYN","LU0124676726.USD","AR","LU1032955483.USD"],"gpt_icon":1},{"id":"2589535914","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2589535914","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589535914?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 22:29","pubTimestamp":1765204182,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场更改日期线，重写标题，增加有关 Structure Therapeutics 公司最新数据的详细信息。诺和诺德计划在 2026 年第一季度将 CagriSema 提交监管部门审批。今年 9 月，MET-097i 在两项中期试验中显示，28 周后平均体重下降 14.1%。服用最高剂量Ozempic的糖尿病患者大约减轻了6%的体重。西兰制药 丹麦生物技术公司西兰制药ZELA.CO去年表示，在一项早期研究中，其减肥候选药物petrelintide的高剂量在每周服用16次后，体重平均减轻了8.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4T3XE15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN.UK","SG9999017495.SGD","02105","LU0943347566.SGD","LU1261432733.SGD","IE0005OL40V9.USD","LU0889565916.HKD","IE0002270589.USD","LU2491050154.USD","LU0672654240.SGD","LU0786609619.USD","AMGN","LU0238689110.USD","LU1974910355.USD","MTSR","SG9999014559.SGD","IE00B3T34201.USD","MRK","LU0889565080.SGD","LU0784385170.HKD","VKTX","SG9999003800.SGD","LU1037948897.HKD","LU1623119135.USD","03692","LU1104425308.USD","GPCR","OPK","03165","BK1191","SRRK","IE00BN8TJ469.HKD","BK4196","LU0960981461.USD","IE0034235188.USD","LU0823416689.USD","ALT","LU2023251221.USD","03933","LU1496350502.SGD","SG9999018865.SGD","BK1583","LU2471134952.CNY","LU1934455863.HKD","LU1232071149.USD","LU1267930813.SGD","LU2471134523.USD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2589535293","title":"Structure 公司的實驗性藥片在研究中顯示可減輕 11% 的體重，股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2589535293","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589535293?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 21:04","pubTimestamp":1765199094,"startTime":"0","endTime":"0","summary":"Structure 公司的实验性药片在研究中显示可减轻 11% 的体重，股价上涨路透12月8日 - Structure Therapeutics GPCR.O周一表示，其肥胖药片在一项中期研究中显示体重下降了11.3%。这家生物技术公司的股票在盘前交易中大涨41.8%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4T3XE0XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}